Eco R1 Capital, LLC Autolus Therapeutics PLC Transaction History
Eco R1 Capital, LLC
- $1.27 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$35.5 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$26.8 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$23.4 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$21.8 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$14.4 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $119M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...